Antifungal activity of saponin-rich extracts of Phytolacca dioica and of the sapogenins obtained through hydrolysis

Natural Product Communications

Volumn 5, Issue 7, 2010, Pages 1013-1018

  Di Liberto, Melina ^a   Svetaz, Laura ^a   Furlán, Ricardo L E ^a   Zacchino, Susana A ^a   Delporte, Carla ^b   Novoa, Marco A ^c   Asencio, Marcelo ^c   Cassels, Bruce K ^b  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSIDAD TECNOLÓGICA METROPOLITANA   (Chile)

Author keywords

Antifungal activity; Phytolaccagenin; Saponins

Indexed keywords

AGLYCONE; AMPHOTERICIN B; KETOCONAZOLE; PHYTOLACCA DIOICA EXTRACT; PHYTOLACCAGENIN; PLANT EXTRACT; SAPOGENIN; SAPONIN; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG HYDROLYSIS; DRUG POTENCY; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYTOLACCA DIOICA; POKEWEED; CHEMISTRY; DRUG EFFECT; HYDROLYSIS; MICROBIOLOGICAL EXAMINATION;

CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; FUNGI; PHYTOLACCA DIOICA;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; HYDROLYSIS; MICROBIAL SENSITIVITY TESTS; PHYTOLACCA; PLANT EXTRACTS; SAPOGENINS; SAPONINS;

EID: 77956640686     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE. (2008) Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clinical and Infectious Diseases, 47, 674-683.
2. Pfaller MA, Diekema DJ. (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clinical and Microbiology Reviews, 20, 133-163.
3. Mathew B, Nath M. (2009) Recent approaches to antifungal therapy for invasive mycoses. ChemMedChem, 4, 310-323.
4. Mukherjee PK, Leidich SD, Isham N, Leitner I., Ryder NS, Ghannoum MA. (2003) Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrobial Agents and Chemotherapy, 47, 82-86. (Pubitemid 36070346)
5. Patterson TF. (2005) Advances and challenges in management of invasive mycoses. Lancet, 366, 1013-1025. (Pubitemid 41323037)
6. Maregesi S, Pieters L, Ngassapa O, Apers S, Vigerhoets R, Cos P, Vanden Berghe D, Vlietink A. (2008) Screening of some Tanzanian medicinal plants from Bunda district for antibacterial, antifungal and antiviral activities. Journal of Ethnopharmacology, 119, 58-66.
7. Cos P, Vlietink A, Vanden Berghe D, Maes L. (2006) Anti-infective potential of natural products: how to develop a stronger in vitro "proof-of-concept". Journal of Ethnopharmacology, 106, 290-302.
8. Agrawal SK, Singh S, Verma S, Kumar S. (2000) Antifungal activity of anthraquinone derivatives from Rheum emodi. Journal of Ethnopharmacology, 72, 43-46.
9. Danelutte AP, Lagoa JH, Young MC, Kato MJ. (2003) Antifungal flavanones and prenylated hydroquinones from Piper crassinervium Kunth. Phytochemistry, 64, 555-559.
10. Malheiros A, Cechinel Filho V, Schmitt C, Yunes R, Escalante A, Svetaz L, Zacchino S, Delle Monache F. (2005) Antifungal activity of drimane sesquiterpenes from Drymis brasiliensis using bioassay-guided fractionation. Journal of Pharmacy and Pharmaceutical Sciences, 8, 335-339. (Pubitemid 41519147)
11. Stein A, Alvarez S, Avancini C, Zacchino S, von Poser G. (2006) Antifungal activity of some coumarins obtained from species of Pterocaulon (Asteraceae). Journal of Ethnopharmacology, 107, 95-98. (Pubitemid 44038816)
12. Agüero M, Alvarez S, Luna L, Feresin G, Derita M, Tapia A, Zacchino S. (2007) Antifungal activity of Zuccagnia punctata Cav. Evidences for the mechanism of action. Planta Medica, 73, 1074-1080.
13. Pacciaroni A, Gette M, Derita M, Ariza Espinar L, Gil R, Zacchino S, Silva G. (2008) Antifungal activity of Heterothalamus alienus metabolites. Phytotherapy Research, 22, 524-528. (Pubitemid 351613419)
14. Oleszek AW. (2000) Saponins. In: Natural Food Antimicrobial Systems, Naidu AS (Ed.). CRC Press, London, 295-324.
15. Sparg S, Light M, Van Staden J. (2004) Biological activities and distribution of plant saponins. Journal of Ethnopharmacology, 94, 239-243.
16. Francis G, Kerem Z, Makkar HPS. (2002) The biological action of saponins in animal systems: a review. The British Journal of Nutrition, 88, 587-605. (Pubitemid 36082888)
17. Kim N, Desjardins A, Wu C, Kinghorn D. (1999) Activity of triterpenoid glycosides from the root bark of Mussaenda macrophylla against two oral pathogens. Journal of Natural Products, 62, 1379-1384. (Pubitemid 29504099)
18. Parkhurst R, Thomas D, Skinner W. (1973) Molluscidal saponins of Phytolacca dodecandra: oleanoglycotoxin. Phytochemistry, 12, 1437-1442.
19. Yi Y. (1991) A triterpenoid saponin from Phytolacca esculenta. Phytochemistry, 30, 2552-2554.
20. Yi Y. (1991) A triterpenoid and its saponin from Phytolacca esculenta. Phytochemistry, 30, 4179-4181.
21. Haraguchi M, Motidome M, Gottlieb O. (1988) Chemical study of the saponins of Phytolacca thyrsiflora. Acta Amazonica 18, 443-448.
22. Woo W, Kang S. (1977) The structure of phytolaccoside G. Journal of the Pharmaceutical Society of Korea, 21, 159-162.
23. Yi Y, Dai F. (1991) A new triterpenoid and its glycoside from Phytolacca esculenta. Planta Medica, 57, 162-164.
24. Slacanin I, Marston A, Hostettmann K. (1988) High-performance liquid chromatographic determination of molluscicidal saponins from Phytolacca dodecandra. Journal of Chromatography, 448, 265-274.
25. Yi Y. (1992) Two new saponins from the roots of Phytolacca esculenta. Planta Medica, 58, 89-101.
26. Escalante AM, Santecchia CB, López SN, Gattuso MA, Gutiérrez Ravelo A, Delle Monache F, González Sierra M, Zacchino SA (2002) Isolation of antifungal saponins from Phytolacca tetramera, an Argentinean species in critical risk. Journal of Ethnopharmacology, 82, 29-34.
27. Soliman HSM, Simon A, Tóth G, Duddeck H (2001) Identification and structure determination of four triterpene saponins from some Middle-East plants. Magnetic Resonance in Chemistry, 39, 567-576. (Pubitemid 33336588)
28. Santander-Andrade P. (1978) Fruit saponins of Phytolacca dioica (ombú). MSc Thesis, Faculty of Sciences, University of Chile.
29. Spengel SM, Luterbacher S, Schaffner W. (1995) New aspects on the chemotaxonomy of Phytolacca dodecandra with regard to the isolation of phytolaccagenin, phytolaccagenic acid and their glycosides. Planta Medica, 61, 385-386.
30. Strauss A, Spengel SM, Schaffner W. (1995) Saponins from root cultures of Phytolacca acinosa. Phytochemistry, 38, 861-865.
31. Woo WS, Kang SS. (1975) The occurrence and chemistry of Phytolacca triterpenoids. Journal of the Pharmaceutical Society of Korea, 19, 189-208.
32. Woo WS, Kang SS. (1976) Phytolaccoside B: Triterpene glucoside from Phytolacca americana. Phytochemistry, 15, 1315-1317.
33. Suga Y, Maruyama Y, Kawanishi S, Shoji J. (1978) Studies on the constituents of Phytolaccaceous plants. I. On the structures of phytolaccasaponin B, E, and G from the roots of Phytolacca americana. Chemical and Pharmaceutical Bulletin, 26, 520-525.
34. Kobayashi A, Hagihara K, Kajiyame S, Kanzaki H, Kawazu K. (1995) Antifungal compounds induced in the dual culture with Phytolacca americana callus and Botrytis fabae. Zeitschrift für Naturforschung C, 50, 398-402.
35. Escalante A, Gattuso A, Pérez P, Zacchino S. (2008) Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman. Journal of Natural Products, 71, 1720-1725.
36. Peláez F, Cabellos A, Platas G, Diez M, González del Val A, Basilio A, Martán I, Vicente F, Bills G, Giacobbe R, Schwartz E, Onishi J, Meinz M, Abruzzo G, Flattery A, Kong L, Kurtz M. (2000) The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species, biological activity and taxonomy of the producing organisms. Systematic and Applied Microbiology, 23, 333-343.
37. López SN, Ramallo IA, González Sierra M, Zacchino SA, Furlán RLE. (2007) Chemically engineered extracts as an alternative source of bioactive natural product-like compounds. Proceedings of the National Academy of Sciences USA, 104, 441-444.
38. Salazar MO, Ramallo IA, Micheloni O, González Sierra M, Furlán RLE. (2009) Chemically engineered extracts: bioactivity alteration through sulfonylation. Bioorganic and Medicinal Chemistry Letters, 19, 5067-5070.
39. Singh N. (2003) Treatment of opportunistic mycoses: how long is long enough? The Lancet Infectious Diseases, 3, 703-708.
40. Clinical and Laboratory Standards Institute (CLSI), formerly National Committee for Clinical Laboratory Standards (NCCLS). (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts and filamentous fungi, approved standard. Vol 22, 2nd ed. NCCLS, Wayne, PA, 1-29.
41. Ernst E, Roling E, Petzold R, Keele D, Klepser M. (2002) In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies. Antimicrobial Agents and Chemotherapy, 46, 3846-3853.
42. nd ed. Springer Verlag (Berlin), 305-326; 335-340; 359.
43. Wright LR, Scott EM, Gorman SP. (1983) The sensitivity of mycelium, arthrospores, and microconidia of Trichophyton mentagrophytes to imidazoles determined by in vitro tests. Journal of Antimicrobial Chemotherapy, 12, 317-327.
44. Rahalison L, Hamburger M, Hostettmann K, Monod M, Frenk E. (1991) A bioautographic agar overlay method for the detection of antifungal compounds from higher plants. Phytochemical Analysis, 2, 199-203.